在产业智能化领域，立项《输变电智能巡视大模型技术应用指南》，以标准规范模型识别检测精 度、速度等指标，提高智能巡检机器人对输变电智能巡视任务的综合理解与处理能力，提升输变电智能 巡视效率。在医养健康领域，立项《医疗机构免陪照护服务规范》，以标准规范免陪照护服务流程，将 有效改善患者就医体验。在政务服务领域，立项《公共数据"一人一档""一企一档"数据规范》，通过标 准化建设保障收集数据的及时性、准确性，为"无证明之省"建设和"高效办成一件事"改革提供坚实数据 支撑。 下一步，省市场监管局将持续加强与相关部门的协调联动，强化标准制定周期管理，高质量完成重 点领域标准研制工作，确保地方标准服务全省经济高质量落地见效。（记者 王鹤颖） "首次运用'揭榜挂帅'形式，旨在引导技术机构、科研院所、高等院校等单位，解决核心领域、关 键环节地方标准研制难题，为山东重点产业升级与民生改善注入标准化动能。"省市场监管局标准化处 相关负责人表示，本批立项项目经过面上摸排、公开征集等方式征集梳理而出，在相关领域具有必要 性、紧迫性。 近日，省市场监管局印发《关于下达2025年第二批地方标准计划和"揭榜挂帅"项目计划的通知》， 聚焦服务 ...

（原标题：杨澜：构建女性赋能ESG生态刻不容缓） 构建女性赋能的ESG生态 女性发展已不是孤立的社会议题，而是ESG"社会维度"的核心载体。 国际劳工组织《生成式人工智能与就业岗位：一份完善的职业暴露风险全球指数》报告显示，生成式人 工智能（AI）对全球工作岗位的潜在影响，在男性和女性之间有很大不同，估计受自动化影响的女性 劳动者比例是男性的2倍以上。 "随着人工智能技术的应用，许多领域进入平权化时代。过去门槛较高的专业培训，如今通过与AI共 创，让门槛大幅降低。自媒体与短视频时代也让普通人的创造力得以展现。"在"2025天下女人国际论 坛"上，资深媒体人、阳光媒体集团董事长杨澜向21世纪经济报道记者表示，更多女性应提升对科技的 好奇心，主动学习并拥抱AI技术，借助技术增强自身职业竞争力，或寻找新的职业发展机会。 杨澜介绍，基于联合国社会调查与分析报告，AI对女性集中行业的冲击大于男性集中行业。例如女性 就业率较高的服务类、客户服务类、商业营销类工作，以及基础助理、研究类工作等较容易被AI取 代；而具备综合性、决策性的工作，则较难被AI长期取代。 但与此同时，新的市场机会也在涌现。"例如大健康领域，以及需要人 ...

（以下无正文，为《中国国际金融股份有限公司关于诺思格（北京）医药科技股份 有限公司 2025 年半年度跟踪报告》之签章页） 保荐代表人： | 中国国际金融股份有限公司 | | --- | | 关于诺思格（北京）医药科技股份有限公司 | | 保荐人名称：中国国际金融股份有限公司 被保荐公司简称：诺思格 | | 保荐代表人姓名：任孟琦 联系电话：010-65051166 | | 保荐代表人姓名：陈贻亮 联系电话：010-65051166 | | 一、保荐工作概述 | | 项 目 工作内容 | | （1）是否及时审阅公司信息披露文件 是 | | （2）未及时审阅公司信息披露文件的次数 0次 | | （1）是否督导公司建立健全规章制度（包括但不 | | 限于防止关联方占用公司资源的制度、募集资金管 是 | | 理制度、内控制度、内部审计制度、关联交易制度） | | （2）公司是否有效执行相关规章制度 是 | | 1 （1）查询公司募集资金专户次数 每月 次 | | （2）公司募集资金项目进展是否与信息披露文件 | | 是 | | 一致 | | （1）列席公司股东大会次数 1次 | | 0 （2）列席公司董事会次数 次 ...

《公 司 2025 年员工持股计划（草案） 诺思格（北京）医药科技股份有限公司（以下简称"公司"）于 2025 年 9 月 5 日召开第四届监事会第十次会议。根据《关于上市公司实施员工持股计划试 点的指导意见》（以下简称"《指导意见》"）、《深圳证券交易所上市公司自律 监管指引第 2 号——创业板上市公司规范运作》 （以下简称"《自律监管指引》"） 等相关法律、法规及规范性文件的规定，经认真审阅相关会议资料及全体监事充 分讨论，现就公司 2025 年员工持股计划（以下简称"本员工持股计划"）相关事 项发表审核意见如下： 《自律监管指引》等法律、法规及规范性文件规 定的禁止实施员工持股计划的情形。 诺思格（北京）医药科技股份有限公司监事会 关于公司 2025 年员工持股计划相关事项的审核意见 》内容符合《指导意见》《自律监管指引》等法 律、法规及规范性文件的规定。 公司及全体股东利益的情形，亦不存在摊派、强行分配等方式强制员工参与本员 工持股计划的情形，不存在公司向员工持股计划持有人提供贷款、贷款担保或任 何其他财务资助的计划或安排。 机制，有利于进一步完善公司治理水平，提高员工的凝聚力和公司竞争力，充分 调动 ...

Financial Data and Key Metrics Changes - The company has increased its estimate of the potential impact of enhanced subsidy expiration from $50 million to a range of $50 million to $100 million, primarily affecting the acute care division [5][4] - The company anticipates same-store revenue growth in the 5% to 7% range, with a midpoint of approximately 6%, split evenly between price and volume [18][19] Business Line Data and Key Metrics Changes - Surgical procedural volumes have been somewhat soft, attributed to challenging comparisons with the previous years when hospitals were recovering from the pandemic [19] - The Cedar Hill hospital, which opened in April, has faced delays in obtaining deemed status from CMS, resulting in an estimated $25 million EBITDA loss in Q2, with expectations of improvement once the status is granted [23][24] Market Data and Key Metrics Changes - Approximately 6% of adjusted acute admissions are exchange patients, which is lower than larger peers like Tenet and HCA, indicating geographical differences in patient demographics [8] - The company has noted that while Medicaid supplemental payments are under scrutiny, they are pursuing three pending programs that could yield an annual benefit of $150 million to $200 million if approved [15][16] Company Strategy and Development Direction - The company is prepared to implement cost efficiencies and other programs to offset potential revenue reductions from the loss of exchange volumes and Medicaid supplemental payments [10][12] - The company is focusing on leveraging technology to improve revenue cycle efficiency and clinical productivity, including the use of AI for post-discharge calls and ER coding [40][41] Management's Comments on Operating Environment and Future Outlook - Management views 2024 and 2025 as the first clean post-COVID years, expecting a return to historically normative growth models [18] - Labor pressures have stabilized, with wage inflation returning to more normative levels of 3% to 4%, and the company is not experiencing significant pressure points in labor costs [30][31] Other Important Information - The company is exploring M&A opportunities, particularly in the acute care sector, but has faced challenges in the behavioral sector due to high multiples for niche providers [55][56] - The company believes it can capture more market share in behavioral care by addressing labor shortages and improving recruitment and retention [50] Q&A Session Summary Question: Update on the potential impact of enhanced subsidies expiration - Management has increased the estimate of potential impact to $50 million to $100 million, primarily in the acute care division [5][4] Question: How is the company planning to offset revenue reductions? - Management indicated they have a menu of options to modify the cost structure and are prepared to react to pressures over the next few years [10][12] Question: What is the outlook for surgical volumes? - Management expects surgical volumes to improve incrementally as the year progresses, although current trends have not changed dramatically [20] Question: Update on Cedar Hill's financial progression - Cedar Hill is expected to improve once deemed status is obtained, with a ramp-up to divisional margins anticipated within 24 months [24][25] Question: How is the company addressing labor challenges? - Management noted that labor pressures have eased, with wage inflation stabilizing and recruitment improving, although challenges remain in some facilities [30][45] Question: What is the outlook for behavioral care rates? - Management expects sustainable same-store revenue growth in the 6% to 7% range, with a mix of price and volume growth [51][52] Question: What are the M&A prospects for the company? - Management is open to M&A opportunities, particularly in the acute care sector, but has faced challenges in the behavioral sector due to high acquisition costs [55][56]

Financial Data and Key Metrics Changes - The company has increased its estimate of the potential impact from the expiration of enhanced subsidies from $50 million to a range of $50 million to $100 million, primarily affecting the acute care division [4][5] - The company reported a $25 million EBITDA loss in Q2 due to delays in obtaining deemed status for the Cedar Hill hospital, with an additional estimated loss of $25 million for the second half of the year [21][23] Business Line Data and Key Metrics Changes - The acute care division is expected to see same-store revenue growth in the range of 5% to 7%, with surgical volumes being somewhat soft compared to previous years [17][18] - The behavioral health segment is experiencing labor shortages, impacting the ability to meet demand, but improvements in recruitment and retention are anticipated [45][48] Market Data and Key Metrics Changes - Approximately 6% of adjusted acute admissions are exchange patients, which is lower than competitors like Tenet and HCA, indicating geographical differences in patient demographics [8] - The company expects to capture more market share in behavioral care as it addresses labor shortages and improves recruitment [51] Company Strategy and Development Direction - The company is prepared to implement cost efficiencies and modify its cost structure in response to potential revenue reductions from the loss of exchange volumes and Medicaid supplemental payments [10][12] - The company is exploring M&A opportunities, particularly in the acute care sector, if financially distressed not-for-profit hospitals become available [57][58] Management's Comments on Operating Environment and Future Outlook - Management described 2024 and 2025 as the first clean post-COVID years, expecting a return to normative growth models [17] - The company is optimistic about the sustainability of its growth rates, particularly in the acute care division, despite some softness in surgical volumes [18][19] Other Important Information - The company is leveraging technology, including AI, to improve operational efficiency and reduce costs in areas such as revenue cycle management and patient follow-up [38][40] - The company anticipates that Medicaid supplemental payment programs pending approval could add $150 million to $200 million annually if approved [14][15] Q&A Session Summary Question: What is the impact of potential subsidy expiration? - Management noted that there is speculation about an extension of subsidies, but they have increased their estimate of the impact on revenue due to potential loss of coverage [4][5] Question: How is the company addressing cost efficiencies? - Management indicated that they have a menu of options to adjust the cost structure and are prepared to react to regulatory changes [10][12] Question: What is the outlook for surgical volumes? - Management expects surgical volumes to improve incrementally as the year progresses, although they have not seen dramatic changes in Q3 [19] Question: What is the status of Cedar Hill hospital? - Cedar Hill is awaiting deemed status approval, which is expected soon, and management anticipates improved financial performance following this approval [22][23] Question: How is the labor market affecting operations? - Management reported that labor pressures have stabilized, with wage inflation returning to more normative levels [26][28] Question: What is the outlook for commercial rates? - Management expects contractual price increases from payers to be in the 4% to 5% range moving forward [33][34] Question: What is the company's approach to M&A? - Management is open to M&A opportunities, particularly in the acute care sector, if financially distressed hospitals become available [57][58]

The U.S. economy added jobs at a slower pace in August amid uncertainty about economic conditions, adding to signs of a weakening labor market. The Labor Department on Friday reported that employers added 22,000 jobs in August, a figure that was well below the 75,000 estimate of economists polled by LSEG.The unemployment rate also rose to 4.3% in August, which was in line with expectations and up from the 4.2% reading in July. The August data follows a similarly soft employment report last month that prompt ...

济民健康(603222)今日下跌8.77%，全天换手率17.07%，成交额9.47亿元，振幅7.12%。龙虎榜数据显 示，营业部席位合计净卖出7636.04万元。 买一 国信证券股份有限公司深圳泰然九路证券营业部 1028.17 买二 东莞证券股份有限公司南京分公司 958.78 上交所公开信息显示，当日该股因日跌幅偏离值达-10.01%上榜，营业部席位合计净卖出7636.04万元。 证券时报·数据宝统计显示，上榜的前五大买卖营业部合计成交1.71亿元，其中，买入成交额为4721.35 万元，卖出成交额为1.24亿元，合计净卖出7636.04万元。 具体来看，今日上榜营业部中，第一大买入营业部为国信证券股份有限公司深圳泰然九路证券营业部， 买入金额为1028.17万元，第一大卖出营业部为国泰海通证券股份有限公司总部，卖出金额为4192.82万 元。 近半年该股累计上榜龙虎榜11次，上榜次日股价平均涨1.50%，上榜后5日平均涨5.91%。 资金流向方面，今日该股主力资金净流出960.97万元，其中，特大单净流出1044.47万元，大单资金净流 入83.50万元。近5日主力资金净流出6900.96万元。 融资融 ...

本员工持股计划的存续期为36个月，自公司公告最后一笔标的股票过户至本员工持股计划名下之日起 算。 诺思格（301333）(301333.SZ)披露2025年员工持股计划(草案)，员工持股计划的资金来源为公司计提的 奖励基金及法律法规允许的其他方式，资金总额不超过1500万元。本员工持股计划股票规模为不超过 38.58万股，标的股票来源为公司回购专用账户中的公司A股，购买回购股票的价格为38.88元/股。 ...

济民健康(603222)今日下跌8.77%，全天换手率17.07%，成交额9.47亿元，振幅7.12%。龙虎榜数据显示，营业部席位合计净卖出7636.04万元。 上交所公开信息显示，当日该股因日跌幅偏离值达-10.01%上榜，营业部席位合计净卖出7636.04万元。 证券时报•数据宝统计显示，上榜的前五大买卖营业部合计成交1.71亿元，其中，买入成交额为4721.35万元，卖出成交额为1.24亿元，合计净卖出 7636.04万元。 具体来看，今日上榜营业部中，第一大买入营业部为国信证券股份有限公司深圳泰然九路证券营业部，买入金额为1028.17万元，第一大卖出营业 部为国泰海通证券股份有限公司总部，卖出金额为4192.82万元。 近半年该股累计上榜龙虎榜11次，上榜次日股价平均涨1.50%，上榜后5日平均涨5.91%。 资金流向方面，今日该股主力资金净流出960.97万元，其中，特大单净流出1044.47万元，大单资金净流入83.50万元。近5日主力资金净流出 6900.96万元。 融资融券数据显示，该股最新（9月4日）两融余额为1.69亿元，其中，融资余额为1.69亿元，融券余额为9.10万元。近5日融资余 ...